City Therapeutics

City Therapeutics

HealthCambridge, United States

City Therapeutics is a biotechnology company focused on developing RNA interference (RNAi) therapies. Their innovative platform utilizes engineered RNAi trigger molecules to deliver treatments beyond the liver, targeting diseases such as thromboembolic disorders and Stargardt disease. The recent $99.5 million funding will support the advancement of their clinical pipeline.

$99.5M · Series BVisit website ↗

Funding history

  1. $99.5MSeries B2026-06-09
    Source: news.google.com ↗

Founder

John Maraganore
John Maraganore
CEO & Co-founder

Investors in City Therapeutics

Backers from this company's tracked funding rounds.

  • Viking Global Investors
  • Sofinnova Investments
  • Casdin Capital
  • NYBC Ventures
  • ARCH Venture Partners
  • Fidelity Management & Research Company
  • Invus
  • Regeneron Ventures

More Health companies

Recently funded startups in the same category.

Related on Datapile